A polyclonal antibody against ELMO1. Recognizes ELMO1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB; Recommended dilution: WB:1:1000-1:5000
BACKGROUND
CD14 is a myeloid differentiation antigen expressed totally on peripheral blood monocytes, dendritic cells and macrophages. It’s a key regulator of inflammatory responses to gram-negative micro organism, oxidative burst and septic shock.
OBJECTIVE
The purpose of this examine was to provide and characterize monoclonal antibody in opposition to CD14 to be used in detection and prognosis of monocytes.
ELMO3 Polyclonal Conjugated Antibody
METHODS
To provide MAb in opposition to CD14 protein, mice have been immunized with two KLH-conjugated CD14 peptides. The spleen cells of the immunized mice have been then fused with SP2/zero by hybridoma approach. Fused cells have been grown in selective medium and cloned by limiting dilution methodology. The specified clones have been chosen and supernatants of hybridoma cells have been screened by ELISA for antibody. Monoclonal antibody was purified by chromatography and confirmed by SDS-PAGE. Lastly, immunoblotting and flowcytometry have been recruited to discover the specificity of the MAb.
RESULTS
Our outcomes confirmed profitable manufacturing and characterization of anti CD14 monoclonal antibody. The MAb was IgG2a with Kappa mild chain and immunobloting and flowcytometry outcomes demonstrated particular reactivity of this MAb with CD14.
Elmo1 Polyclonal Antibody | C-Peptide Blocking Peptide | Anti-ELMO1 antibody
CONCLUSIONS
The outcomes present that, the produced anti- CD14 MAb is extremely particular and useful in biomedical functions reminiscent of move cytometry and western blotting and could possibly be utilized for identification of monocytes.

ELMO3 Polyclonal Conjugated Antibody | Polyclonal Goat Anti-ELMO3 Antibody
- The goals of those research have been to find out the talents of antisera in opposition to completely different areas of ovine bone morphogenetic protein 15 (BMP15) and progress differentiation issue 9 (GDF9) to inhibit ovarian follicular exercise, estrus (mating), and ovulation in sheep. The 9-15-mer peptides have been conjugated to keyhole limpet hemocyanin (KLH) and used to generate antibodies in opposition to the versatile N-terminal areas of the mature protein in addition to in opposition to areas by which dimerization of the protein or interplay with a sort 1 BMP or a sort 2 TGFB or BMP receptor was predicted to happen.
Dyskerin Blocking Peptide | Rat ELMO3 shRNA Plasmid | ELMO3 Polyclonal Antibody
- Ewes (n = 10 per therapy group) have been vaccinated with KLH or the KLH-BMP15 (n = 9 completely different peptides) or KLH-GDF9 (n = 10) peptides in Freund adjuvant at 5 consecutive month-to-month intervals. Total, antisera generated in opposition to peptides that corresponded to amino acid residues 1-15 of the N-terminus of the BMP15 or GDF9 mature protein or GDF9 amino acid residues 21-34 have been essentially the most potent at inhibiting ovulation following major and single booster vaccination.
- A number of different BMP15 (8/9) or GDF9 (6/10) therapy teams, however not KLH alone, additionally produced vital reductions within the numbers of animals that ovulated, though 2, Three or four booster vaccinations have been required.
- Anovulation was generally related to the inhibition of regular ovarian follicular growth and anestrus. The in vitro neutralization research with IgG from the BMP15 or GDF9 immunized ewes confirmed that the imply inhibition of BMP15 plus GDF9 stimulation of (3)H-thymidine uptake by rat granulosa cells was roughly 70% for animals with out corpora lutea (CL), whereas for animals with one to 3 CL or greater than three CL, the inhibition was 24%-33% or 27%-42%, respectively.
- In abstract, these knowledge counsel that reagents that block the organic actions of BMP15 or GDF9 at their N-termini have potential as contraceptives or sterilizing brokers.
